Cargando…
Natriuretic peptides are neuroprotective on in vitro models of PD and promote dopaminergic differentiation of hiPSCs-derived neurons via the Wnt/β-catenin signaling
Over the last 20 years, the efforts to develop new therapies for Parkinson’s disease (PD) have focused not only on the improvement of symptomatic therapy for motor and non-motor symptoms but also on the discovering of the potential causes of PD, in order to develop disease-modifying treatments. The...
Autores principales: | Giovannini, Daniela, Andreola, Federica, Spitalieri, Paola, Krasnowska, Ewa Krystyna, Colini Baldeschi, Arianna, Rossi, Simona, Sangiuolo, Federica, Cozzolino, Mauro, Serafino, Annalucia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560781/ https://www.ncbi.nlm.nih.gov/pubmed/34725335 http://dx.doi.org/10.1038/s41420-021-00723-6 |
Ejemplares similares
-
Atrial Natriuretic Peptide Acts as a Neuroprotective Agent in in Vitro Models of Parkinson’s Disease via Up-regulation of the Wnt/β-Catenin Pathway
por: Colini Baldeschi, Arianna, et al.
Publicado: (2018) -
Generation and Neuronal Differentiation of hiPSCs From Patients With Myotonic Dystrophy Type 2
por: Spitalieri, Paola, et al.
Publicado: (2018) -
Organoid factory: The recent role of the human induced pluripotent stem cells (hiPSCs) in precision medicine
por: Novelli, Giuseppe, et al.
Publicado: (2023) -
Dopaminergic differentiation of schizophrenia hiPSCs
por: Hartley, Brigham J., et al.
Publicado: (2015) -
Effects of Simulated Microgravity on Wild Type and Marfan hiPSCs-Derived Embryoid Bodies
por: Spitalieri, Paola, et al.
Publicado: (2021)